ID

41693

Description

The primary objective of this study was to demonstrate bioequivalence between eltrombopag oral film-coated tablets manufactured at Research and Development (R&D) and Commercial sites. The subject participants each went through two dosing periods (Period 1 and Period 2), during each of which they received a single dose of eltrombopag. The dosing periods were separated by a washout of at least 10 days. For each period, subjects had to perform a visit on the day before and one on the day of the administration of the drug. Furthermore, the protocol-defined visits included a screening visit and a follow-up visit. Study ID: 105122 Clinical Study ID: 105122 Study Title: Phase I Bioequivalence Study for SB 497115 GR Phase II and Phase III Tablets Sponsor: GlaxoSmithKline Phase: phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Study Indication: Thrombocytopenia This form has to be filled out at the Follow-Up Visit.

Keywords

  1. 12/18/20 12/18/20 -
Copyright Holder

GlaxoSmithKline

Uploaded on

December 18, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Eltrombopag Thrombocytopenia, Clinical Study ID: 105122

Study Conclusion and Pregnancy Information

Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
date of visit
Description

date of visit

Data type

date

Alias
UMLS CUI [1]
C1320303
subject ID
Description

subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Study Conclusion
Description

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008976
date and time of subject completion or withdrawal
Description

date and time of subject completion or withdrawal

Data type

datetime

Alias
UMLS CUI [1,1]
C2348577
UMLS CUI [1,2]
C0011008
UMLS CUI [2,1]
C2348577
UMLS CUI [2,2]
C0040223
UMLS CUI [3,1]
C1710677
UMLS CUI [3,2]
C0011008
UMLS CUI [4,1]
C1710677
UMLS CUI [4,2]
C0040223
was the subject withdrawn from the study?
Description

subject withdrawn from study

Data type

text

Alias
UMLS CUI [1]
C0422727
if the subject was withdrawn from the study, please specify primary reason for withdrawal:
Description

subject withdrawn from study; primary reason

Data type

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1549995
if other reason for withdrawal, please specify:
Description

other reason for withdrawal, specification

Data type

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1549995
UMLS CUI [1,3]
C2348235
case book ready for signature
Description

Data owner should check the box when data cleaning is complete

Data type

text

Alias
UMLS CUI [1,1]
C1516308
UMLS CUI [1,2]
C1519316
office use 1
Description

office use 1

Data type

boolean

Alias
UMLS CUI [1,1]
C0442603
UMLS CUI [1,2]
C1524063
office use 2
Description

office use 2

Data type

text

Alias
UMLS CUI [1,1]
C0442603
UMLS CUI [1,2]
C1524063
Pregnancy information
Description

Pregnancy information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
did the subject become pregnant during the study?
Description

if yes, complete the paper Pregnancy Notification form

Data type

boolean

Alias
UMLS CUI [1]
C3828490
did a female partner of the male subject become pregnant during the study?
Description

If Yes, complete the paper Pregnancy Notification form

Data type

text

Alias
UMLS CUI [1,1]
C3828490
UMLS CUI [1,2]
C0919624

Similar models

Study Conclusion and Pregnancy Information

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
date of visit
Item
date of visit
date
C1320303 (UMLS CUI [1])
subject ID
Item
subject ID
text
C2348585 (UMLS CUI [1])
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
date and time of subject completion or withdrawal
Item
date and time of subject completion or withdrawal
datetime
C2348577 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C2348577 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1710677 (UMLS CUI [3,1])
C0011008 (UMLS CUI [3,2])
C1710677 (UMLS CUI [4,1])
C0040223 (UMLS CUI [4,2])
Item
was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Code List
was the subject withdrawn from the study?
CL Item
Yes (1)
CL Item
2 No (2 No)
Item
if the subject was withdrawn from the study, please specify primary reason for withdrawal:
text
C0422727 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Code List
if the subject was withdrawn from the study, please specify primary reason for withdrawal:
CL Item
Adverse event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (5)
CL Item
Other (6)
other reason for withdrawal, specification
Item
if other reason for withdrawal, please specify:
text
C0422727 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item
case book ready for signature
text
C1516308 (UMLS CUI [1,1])
C1519316 (UMLS CUI [1,2])
Code List
case book ready for signature
CL Item
Yes (1)
office use 1
Item
office use 1
boolean
C0442603 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Item
office use 2
text
C0442603 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Code List
office use 2
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
CL Item
8 (8)
CL Item
9 (9)
Item Group
Pregnancy information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
subject becoming pregnant during study
Item
did the subject become pregnant during the study?
boolean
C3828490 (UMLS CUI [1])
Item
did a female partner of the male subject become pregnant during the study?
text
C3828490 (UMLS CUI [1,1])
C0919624 (UMLS CUI [1,2])
Code List
did a female partner of the male subject become pregnant during the study?
CL Item
No (1)
CL Item
Yes  (2)
CL Item
Not applicable (female partner not of childbearing potential or no female partner) (3)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial